Hartford Hospital

Hartford Hospital was paid $316.28M by Medicaid between Jan 2018 and Dec 2024, across 893 billing codes. Its largest line is 99285, emergency room visit (most serious) — 17% of everything it billed.

33Billing provider infoHARTFORD HOSPITAL
HARTFORD, CT 06102

33aNPI1770696643assigned 08/16/2006

33bProvider typeDental Clinic/Center

28Total paid$316.28M

24GClaims7,407,519

24DCodes billed893

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Dental Clinic/Center providers in Connecticut

Rank by total paid#1 of 78

Median peer was paid$192K

This provider vs. median1,646×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,031,287	$40.17M
2019	1,001,492	$40.63M
2020	922,624	$37.33M
2021	1,184,903	$46.25M
2022	1,110,536	$48.90M
2023	1,138,111	$53.43M
2024incomplete	1,018,566	$49.57M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	17%	105,392	86,273	$55.05M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.8%	106,844	92,479	$31.13M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	8.1%	293,204	218,070	$25.72M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	6.9%	403,235	112,061	$21.67M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.8%	90,358	77,677	$18.37M
S9480	Intensive outpatient psychiatric services, per diem	2.7%	84,832	9,522	$8.62M
J9271	Injection, pembrolizumab, 1 mg	2.7%	1,678	1,081	$8.45M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.3%	52,522	44,001	$7.40M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	1.4%	6,287	5,012	$4.31M
59025	Fetal non-stress test	1.0%	20,020	8,713	$3.18M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	17,326	8,572	$3.07M
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	1,634	1,302	$3.05M

881 more codes

97010		<1%	112,146	$2.98M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	24,061	$2.87M
19318		<1%	536	$2.81M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	18,248	$2.73M
71046	Radiologic examination, chest; 2 views	<1%	45,389	$2.49M
96361	Intravenous infusion, hydration; each additional hour	<1%	45,330	$2.28M
58661		<1%	454	$2.24M
90935	Hemodialysis procedure with single evaluation by a physician	<1%	6,032	$2.20M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	5,640	$2.16M
93458		<1%	1,596	$2.08M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,103	$2.06M
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	13,202	$2.04M
72125	Computed tomography, cervical spine; without contrast material	<1%	12,038	$2.03M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	2,602	$2.00M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,888	$2.00M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	30,136	$1.93M
97161		<1%	33,865	$1.92M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	15,069	$1.80M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	347	$1.70M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	14,005	$1.70M
96375	Therapeutic injection; each additional sequential IV push	<1%	42,558	$1.64M
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,247	$1.57M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,743	$1.52M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	18,642	$1.46M
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	153,178	$1.42M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	8,103	$1.39M
47562		<1%	344	$1.37M
95811		<1%	1,948	$1.35M
A0436	Rotary wing air mileage, per statute mile	<1%	1,633	$1.31M
90834	Psychotherapy session, about 45 minutes	<1%	24,689	$1.25M
77386		<1%	6,537	$1.24M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	4,504	$1.19M
93798		<1%	16,874	$1.17M
77412		<1%	9,359	$1.16M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,660	$1.16M
71045	Radiologic examination, chest; single view	<1%	23,761	$1.15M
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	255,395	$1.14M
97035		<1%	17,758	$1.10M
70450	Computed tomography, head or brain; without contrast material	<1%	24,486	$1.08M
27447		<1%	455	$972K
49083		<1%	2,205	$962K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,284	$949K
97162		<1%	20,733	$937K
J2505	Injection, pegfilgrastim, 6 mg	<1%	515	$919K
97597		<1%	10,756	$917K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	1,308	$909K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	8,844	$900K
99214	Doctor's office visit, returning patient (more involved)	<1%	9,820	$865K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	1,449	$859K
70496		<1%	4,009	$857K
77334		<1%	2,592	$856K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,523	$845K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	6,331	$836K
J9035	Injection, bevacizumab, 10 mg	<1%	602	$828K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	7,301	$815K
76801		<1%	7,505	$776K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	10,664	$752K
76830	Ultrasound, transvaginal	<1%	6,785	$671K
D7140	Extraction, erupted tooth or exposed root	<1%	14,392	$635K
93975		<1%	3,272	$633K
J0897	Injection, denosumab, 1 mg	<1%	909	$629K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,535	$615K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	578	$607K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	6,192	$590K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	26,266	$588K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	42,736	$582K
99213	Doctor's office visit, returning patient (routine)	<1%	10,515	$578K
66982		<1%	698	$558K
58558		<1%	276	$551K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	54,793	$549K
86900		<1%	41,838	$534K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	2,104	$533K
90791	Psychiatric diagnostic evaluation	<1%	5,913	$521K
90870		<1%	3,661	$507K
64450		<1%	711	$470K
78431		<1%	664	$469K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,185	$469K
77336		<1%	6,848	$464K
J9299	Injection, nivolumab, 1 mg	<1%	164	$460K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	22,628	$459K
94060		<1%	2,655	$456K
52356		<1%	137	$454K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	28,684	$449K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	28,724	$449K
36224		<1%	103	$440K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	4,104	$436K
97165		<1%	6,471	$425K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,828	$423K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	3,780	$415K
88184		<1%	3,715	$413K
20610		<1%	1,850	$412K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,140	$399K
43235		<1%	936	$390K
J0185	Injection, aprepitant, 1 mg	<1%	3,396	$385K
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	<1%	3,124	$383K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	9,914	$375K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	6,021	$360K
36430		<1%	2,291	$348K
77300		<1%	1,891	$346K
58571		<1%	68	$343K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	3,406	$326K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	9,753	$325K
64400		<1%	1,234	$312K
97014		<1%	6,007	$301K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	106,722	$299K
96367		<1%	6,409	$270K
96415		<1%	4,794	$265K
97113		<1%	4,727	$264K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	140	$262K
77065	Tomosynthesis, mammo	<1%	2,350	$261K
93971		<1%	3,712	$256K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	31,713	$252K
90651		<1%	1,022	$251K
77066	Tomosynthesis, mammo	<1%	1,990	$243K
76813		<1%	2,640	$238K
97166		<1%	4,242	$234K
0002A		<1%	7,333	$232K
0001A		<1%	7,730	$231K
J0485	Injection, belatacept, 1 mg	<1%	1,532	$231K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,339	$231K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	577	$224K
64405		<1%	1,010	$223K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	24,856	$221K
97535	Self-care/home management training, each 15 minutes	<1%	10,202	$220K
93970		<1%	1,804	$218K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,531	$216K
99215	Doctor's office visit, returning patient (complex)	<1%	2,129	$215K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,995	$213K
97012		<1%	4,142	$207K
64615		<1%	987	$200K
10060		<1%	1,248	$198K
90746		<1%	3,475	$197K
96417		<1%	4,669	$193K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	67	$192K
95909		<1%	806	$190K
86780		<1%	17,806	$188K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	1,105	$187K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	839	$181K
76642		<1%	2,629	$174K
90832	Psychotherapy session, about 30 minutes	<1%	7,855	$172K
74174		<1%	1,275	$160K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	264	$156K
90677		<1%	1,022	$155K
10061		<1%	433	$148K
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	<1%	2,524	$147K
H2012	Behavioral health day treatment, per hour	<1%	2,674	$146K
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	32	$144K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	18,510	$143K
95708		<1%	260	$141K
D1110	Prophylaxis - adult	<1%	5,765	$140K
80061	Lipid panel	<1%	16,550	$139K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	243,794	$136K
97163		<1%	3,299	$135K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	4,129	$135K
93296		<1%	7,887	$133K
90837	Psychotherapy session, about an hour	<1%	1,633	$129K
76825		<1%	277	$122K
74183		<1%	595	$122K
58300		<1%	754	$122K
77295		<1%	174	$119K
88342		<1%	6,068	$119K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	26,888	$117K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	6,776	$111K
71250		<1%	2,201	$108K
93976		<1%	1,078	$108K
86870		<1%	723	$107K
D0210	Intraoral - complete series of radiographic images	<1%	3,230	$107K
76770		<1%	1,288	$106K
93308		<1%	873	$106K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	944	$106K
77301		<1%	176	$105K
93460		<1%	79	$104K
74240		<1%	754	$104K
97116		<1%	8,685	$99K
92557		<1%	984	$98K
87536		<1%	5,489	$97K
91010		<1%	303	$96K
70491		<1%	590	$95K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	897	$94K
95700		<1%	599	$94K
95816		<1%	614	$89K
91200		<1%	1,572	$89K
92610		<1%	1,079	$88K
43259		<1%	90	$88K
77290		<1%	428	$87K
96411		<1%	1,718	$86K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	6,834	$86K
90739		<1%	754	$84K
90686		<1%	6,094	$83K
D0140	Limited oral evaluation - problem focused	<1%	3,604	$80K
93505		<1%	55	$80K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	364	$80K
74220		<1%	830	$78K
85097		<1%	494	$78K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	1,216	$77K
97167		<1%	1,668	$77K
90732		<1%	1,079	$77K
D0120	Dental checkup, returning patient	<1%	4,739	$76K
27130		<1%	27	$75K
0011A		<1%	2,583	$72K
52332		<1%	57	$71K
76641		<1%	801	$71K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,692	$71K
D0330	Panoramic radiographic image	<1%	2,978	$68K
84443	Thyroid stimulating hormone (TSH)	<1%	21,547	$68K
58301		<1%	359	$67K
0012A		<1%	2,188	$66K
97164		<1%	4,672	$66K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	8,745	$65K
72141		<1%	487	$64K
36415	Collection of venous blood by venipuncture	<1%	280,264	$64K
80053	Comprehensive metabolic panel	<1%	117,670	$64K
92526		<1%	1,469	$64K
77280		<1%	713	$62K
86480		<1%	4,275	$62K
57454		<1%	244	$61K
D9310		<1%	3,993	$60K
88360		<1%	1,374	$60K
36591		<1%	3,180	$56K
86832		<1%	1,035	$56K
93017		<1%	4,091	$56K
20553		<1%	578	$55K
73564		<1%	9,754	$55K
95806		<1%	450	$53K
86833		<1%	1,018	$53K
J3032	Injection, eptinezumab-jjmr, 1 mg	<1%	14	$51K
0004A		<1%	1,575	$51K
70486		<1%	2,939	$51K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	16,766	$51K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	171	$49K
36821		<1%	29	$49K
73700		<1%	871	$49K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	55,430	$47K
77338		<1%	284	$46K
95911		<1%	107	$46K
83036	Hemoglobin; glycosylated (A1C)	<1%	37,090	$46K
D0274	Bitewings - four radiographic images	<1%	1,756	$45K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,320	$43K
94010		<1%	556	$42K
75561		<1%	170	$42K
43237		<1%	41	$41K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	637	$41K
97760		<1%	1,130	$41K
90792	Psychiatric diagnostic evaluation with medical services	<1%	777	$40K
90670		<1%	588	$39K
95910		<1%	166	$39K
81455		<1%	413	$37K
36561		<1%	12	$36K
86803		<1%	10,393	$36K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,415	$34K
96402		<1%	1,847	$34K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,909	$33K
64721		<1%	28	$33K
20552		<1%	271	$32K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	571	$32K
D9223	Deep sedation/general anesthesia - each subsequent 15 minute increment	<1%	455	$31K
0031A		<1%	1,435	$31K
95912		<1%	67	$31K
76536		<1%	482	$30K
83880		<1%	19,575	$30K
72110		<1%	1,051	$30K
0064A		<1%	936	$29K
11982		<1%	186	$29K
20600		<1%	140	$29K
Q5114	Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg	<1%	23	$29K
80048	Basic metabolic panel (calcium, ionized)	<1%	100,241	$28K
86361		<1%	4,814	$28K
78451		<1%	81	$28K
81003		<1%	109,369	$28K
72197		<1%	88	$28K
96116		<1%	583	$27K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	146	$27K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	804	$26K
88173		<1%	1,707	$26K
73130		<1%	7,474	$26K
81025		<1%	76,749	$25K
29405		<1%	108	$25K
J1453	Injection, fosaprepitant, 1 mg	<1%	206	$25K
82947		<1%	8,254	$25K
70498		<1%	4,046	$24K
73030		<1%	8,022	$24K
98968		<1%	1,134	$23K
72100		<1%	4,479	$21K
D9222		<1%	424	$21K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	53	$21K
31575		<1%	202	$21K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	267	$20K
51702		<1%	965	$20K
99205	Prolong outpt/office vis	<1%	147	$20K
Q0222	Injection, bebtelovimab, 175 mg	<1%	45	$20K
96133		<1%	308	$19K
85027		<1%	23,895	$19K
98967		<1%	708	$19K
96137		<1%	304	$19K
87340		<1%	10,542	$18K
84702		<1%	10,691	$18K
87086	Culture, bacterial; quantitative colony count, urine	<1%	28,058	$18K
78816		<1%	14	$18K
11043		<1%	56	$17K
73630		<1%	6,714	$17K
95715		<1%	30	$17K
80164		<1%	3,446	$17K
19083		<1%	14	$17K
G0378	Hospital observation service, per hour	<1%	33,026	$17K
29125		<1%	736	$16K
92523		<1%	100	$16K
20561		<1%	1,163	$16K
73610		<1%	9,016	$16K
90734		<1%	131	$16K
93312		<1%	71	$16K
19081		<1%	13	$16K
19301		<1%	14	$15K
D0150	Comprehensive oral evaluation - new or established patient	<1%	616	$15K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	42	$15K
76818		<1%	123	$15K
95819		<1%	168	$15K
96132		<1%	424	$15K
73110		<1%	5,479	$15K
97168		<1%	840	$14K
D0220	Intraoral - periapical first radiographic image	<1%	1,489	$14K
74420		<1%	990	$14K
90674		<1%	811	$14K
58100		<1%	98	$14K
97124		<1%	483	$14K
93280		<1%	1,114	$14K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	299	$14K
82607		<1%	5,411	$13K
78492		<1%	17	$13K
72158		<1%	47	$13K
0054A		<1%	432	$13K
84146		<1%	1,249	$12K
D1206	Topical application of fluoride varnish	<1%	636	$12K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	45	$12K
0003A		<1%	364	$12K
77080		<1%	121	$12K
73502		<1%	4,253	$12K
80159		<1%	934	$11K
74230		<1%	138	$11K
72156		<1%	68	$11K
51701		<1%	278	$10K
95953		<1%	25	$10K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,555	$10K
73562		<1%	1,642	$10K
75574		<1%	87	$10K
96409		<1%	117	$10K
84439		<1%	4,468	$10K
64644		<1%	41	$10K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	28	$9K
78803		<1%	13	$9K
88307		<1%	4,107	$9K
76970		<1%	114	$9K
72131		<1%	687	$9K
97763		<1%	644	$9K
71271		<1%	91	$9K
94660		<1%	2,692	$9K
51798		<1%	424	$9K
77470		<1%	53	$9K
91320		<1%	173	$9K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	18	$8K
96523		<1%	436	$8K
82746		<1%	3,549	$8K
0124A		<1%	306	$8K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	96	$8K
D1120	Dental cleaning, child	<1%	202	$8K
87077		<1%	12,979	$8K
97032		<1%	183	$8K
95250		<1%	124	$8K
74018		<1%	2,064	$8K
86923		<1%	1,607	$8K
82728		<1%	4,947	$7K
0071A		<1%	203	$7K
43264		<1%	12	$7K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	17	$7K
94618		<1%	193	$7K
73140		<1%	2,388	$7K
87522	Neg quan hep c or qual rna	<1%	954	$7K
80074		<1%	722	$7K
78306		<1%	34	$7K
0072A		<1%	201	$7K
86706		<1%	6,123	$6K
80178		<1%	2,166	$6K
74019		<1%	1,004	$6K
80076		<1%	22,978	$6K
88344		<1%	30	$6K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	13,654	$6K
D5110		<1%	17	$6K
97018		<1%	138	$6K
93298		<1%	283	$6K
90747		<1%	60	$6K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	3,831	$6K
73552		<1%	2,691	$6K
73590		<1%	4,482	$6K
73080		<1%	2,222	$6K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	82	$5K
87205		<1%	12,500	$5K
90694		<1%	285	$5K
87210		<1%	6,999	$5K
93282		<1%	318	$5K
72070		<1%	499	$5K
12001		<1%	1,830	$5K
20560		<1%	563	$5K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	69	$5K
10022		<1%	17	$5K
83550		<1%	4,618	$5K
72170		<1%	2,270	$5K
83735		<1%	54,792	$5K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	12	$5K
87186		<1%	8,177	$4K
84484		<1%	67,269	$4K
95992		<1%	757	$4K
92611		<1%	44	$4K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	56,435	$4K
52000		<1%	12	$4K
73560		<1%	685	$4K
D9243		<1%	73	$4K
96136		<1%	310	$4K
76882		<1%	135	$4K
Q3014	Telehealth originating site facility fee	<1%	2,296	$4K
86318		<1%	896	$4K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	15	$4K
82374		<1%	4,968	$4K
83540		<1%	5,075	$4K
82962		<1%	147,472	$4K
87081		<1%	5,395	$4K
72040		<1%	785	$4K
20550		<1%	18	$4K
76870		<1%	561	$4K
78264		<1%	18	$3K
82570		<1%	5,334	$3K
93270		<1%	563	$3K
36592		<1%	87	$3K
86787		<1%	4,854	$3K
99204	Doctor's office visit, new patient (more involved)	<1%	32	$3K
86704		<1%	1,941	$3K
12002		<1%	1,181	$3K
51729		<1%	12	$3K
97799		<1%	797	$3K
97810		<1%	905	$3K
93926		<1%	66	$3K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	29	$3K
J3300	Injection, triamcinolone acetonide, preservative free, 1 mg	<1%	23	$3K
41899	Unlisted procedure, dentoalveolar structures	<1%	26	$3K
51784		<1%	40	$3K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	80	$3K
93283		<1%	168	$3K
86317		<1%	1,916	$3K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	130	$3K
85610		<1%	53,763	$3K
73060		<1%	1,925	$3K
77307		<1%	12	$3K
86762		<1%	4,579	$3K
73090		<1%	2,405	$3K
J9395	Injection, fulvestrant, 25 mg	<1%	31	$2K
73120		<1%	110	$2K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	15	$2K
77085		<1%	26	$2K
D2150	Silver amalgam - two surfaces, primary or permanent	<1%	44	$2K
82435		<1%	4,962	$2K
0034A		<1%	64	$2K
96401		<1%	363	$2K
82565		<1%	10,839	$2K
84703		<1%	4,658	$2K
83690		<1%	47,904	$2K
83615		<1%	7,922	$2K
84156		<1%	3,918	$2K
86593		<1%	647	$2K
82140		<1%	1,677	$2K
86140		<1%	7,955	$2K
91122		<1%	13	$2K
70546		<1%	19	$2K
90715		<1%	14,134	$2K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	347	$2K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,975	$2K
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	1,125	$2K
99407		<1%	938	$2K
84152		<1%	693	$2K
82043		<1%	3,237	$2K
86850		<1%	39,392	$2K
D2332		<1%	23	$2K
93284		<1%	124	$2K
80051		<1%	1,821	$2K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	19	$2K
88237		<1%	420	$2K
97130		<1%	50	$2K
86304		<1%	1,356	$1K
0052A		<1%	41	$1K
87070		<1%	7,191	$1K
72128		<1%	611	$1K
82105		<1%	764	$1K
D2331		<1%	25	$1K
82652		<1%	68	$1K
D0230	Intraoral - periapical each additional radiographic image	<1%	133	$1K
71101		<1%	797	$1K
85014		<1%	11,247	$1K
12011		<1%	931	$1K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	14	$1K
85730		<1%	5,634	$1K
87641		<1%	3,168	$1K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,150	$1K
88313		<1%	2,247	$999.89
82550		<1%	22,708	$998.67
84100		<1%	15,470	$975.13
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	463	$968.67
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	13	$965.69
73070		<1%	626	$958.05
92552		<1%	314	$920.88
86901		<1%	41,661	$911.14
82803		<1%	4,864	$896.65
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	21	$889.72
88112		<1%	727	$875.53
82677		<1%	340	$854.33
82150		<1%	2,992	$851.78
85018		<1%	8,266	$847.68
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	10,602	$835.95
88264		<1%	361	$833.21
87507		<1%	87	$796.04
88304		<1%	3,305	$791.29
83605		<1%	16,011	$786.22
84403		<1%	225	$772.57
86709		<1%	123	$763.25
73000		<1%	222	$739.36
86696		<1%	79	$702.24
86708		<1%	108	$688.78
81001		<1%	15,105	$677.73
84134		<1%	3,117	$630.69
95012		<1%	248	$618.92
84466		<1%	3,203	$600.63
82330		<1%	2,820	$580.21
86695		<1%	94	$579.60
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	651	$559.63
86336		<1%	341	$550.56
85652		<1%	7,071	$544.69
70355		<1%	1,972	$532.55
0051A		<1%	13	$520.00
83970		<1%	1,282	$519.52
20611		<1%	15	$512.60
87040		<1%	13,092	$492.94
88142		<1%	63	$489.26
73523		<1%	16	$483.33
0013A		<1%	14	$480.00
83721		<1%	207	$446.39
83021		<1%	486	$413.76
84704		<1%	340	$412.18
81050		<1%	2,166	$408.05
82553		<1%	8,302	$405.02
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	104	$398.02
93880		<1%	12	$393.80
84550		<1%	3,982	$391.95
92567		<1%	1,152	$379.07
85660		<1%	2,681	$362.75
76775		<1%	80	$355.27
J7120	Ringers lactate infusion, up to 1000 cc	<1%	50,133	$353.24
86920		<1%	57	$321.28
84450		<1%	3,106	$319.66
94727		<1%	2,315	$307.06
87493		<1%	109	$301.59
76000		<1%	28	$300.44
86922		<1%	333	$274.63
76820		<1%	807	$272.91
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	39,961	$265.67
88280		<1%	445	$263.67
80197		<1%	1,123	$262.20
87075		<1%	2,453	$261.59
84132		<1%	9,527	$250.69
84478		<1%	68	$246.54
85379		<1%	5,074	$242.00
82248		<1%	159	$210.47
96377		<1%	290	$210.12
82040		<1%	1,547	$206.31
85045		<1%	958	$205.82
70360		<1%	100	$203.96
84145		<1%	5,223	$202.16
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	75	$188.72
99406		<1%	265	$182.32
73600		<1%	108	$182.18
76937		<1%	1,090	$178.12
87184		<1%	677	$172.42
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	23	$170.80
J7030	Infusion, normal saline solution , 1000 cc	<1%	91,039	$166.56
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	13	$166.00
86618		<1%	253	$163.01
82977		<1%	62	$161.00
87015		<1%	1,441	$159.50
82010		<1%	3,951	$155.31
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,223	$155.20
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,572	$154.50
J1170	Injection, hydromorphone, up to 4 mg	<1%	19,565	$154.35
85007		<1%	335	$149.71
87206		<1%	1,550	$145.41
81002		<1%	8,226	$145.15
82784		<1%	69	$142.08
82375		<1%	291	$141.24
87102		<1%	1,001	$136.34
87529		<1%	15	$134.04
96368		<1%	1,474	$129.59
J1644	Injection, heparin sodium, per 1000 units	<1%	33,327	$123.75
82247		<1%	49	$122.74
83930		<1%	2,221	$120.56
J2060	Injection, lorazepam, 2 mg	<1%	5,370	$116.04
87116		<1%	641	$113.52
86038		<1%	75	$108.66
89051		<1%	2,641	$107.25
80177		<1%	440	$98.09
82378		<1%	21	$93.85
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,790	$90.47
80179		<1%	284	$82.20
J2359	Injection, olanzapine, 0.5 mg	<1%	19	$81.58
94729		<1%	2,655	$81.08
G0010	Administration of hepatitis b vaccine	<1%	1,797	$80.00
86703		<1%	43	$78.54
82310		<1%	1,874	$75.32
J1953	Injection, levetiracetam, 10 mg	<1%	520	$72.53
84165		<1%	40	$71.82
84520		<1%	10,107	$71.02
73650		<1%	32	$69.15
87106		<1%	26	$69.02
86705		<1%	12	$67.50
84075		<1%	1,918	$67.21
84295		<1%	5,663	$66.65
85041		<1%	487	$66.00
80143		<1%	298	$65.76
96376		<1%	13,545	$63.95
82077		<1%	1,225	$60.92
85520		<1%	157	$58.45
87088		<1%	84	$54.18
88185		<1%	3,698	$53.61
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	45,469	$53.44
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	25,997	$50.88
84460		<1%	3,116	$42.02
87799		<1%	31	$40.91
87581		<1%	104	$33.51
87486		<1%	104	$33.51
95851		<1%	154	$32.65
83050		<1%	100	$31.68
85347		<1%	2,050	$28.49
86431		<1%	44	$27.10
82670		<1%	14	$26.68
J1836	Injection, metronidazole, 10 mg	<1%	684	$26.52
82800		<1%	329	$25.01
86200		<1%	28	$24.72
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	39,709	$21.00
G0009	Administration of pneumococcal vaccine	<1%	1,749	$20.00
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	106	$18.58
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	4,944	$18.46
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,817	$17.60
80069		<1%	63	$16.60
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	3,666	$15.93
82075		<1%	317	$15.84
85049		<1%	101	$11.22
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	11,245	$11.12
J3490	Unclassified drugs	<1%	830,512	$10.92
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	9,778	$10.88
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	1,806	$10.83
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,832	$10.49
J1921	Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg	<1%	302	$10.36
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	1,670	$9.60
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	31,278	$8.23
85384		<1%	45	$8.11
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	22,212	$7.23
84155		<1%	14	$7.00
J1940	Injection, furosemide, up to 20 mg	<1%	4,809	$6.87
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	22	$6.30
G0008	Administration of influenza virus vaccine	<1%	5,459	$6.18
J7050	Infusion, normal saline solution, 250 cc	<1%	26,134	$5.92
86308		<1%	142	$5.34
J1790	Injection, droperidol, up to 5 mg	<1%	2,672	$5.33
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	512	$4.83
82945		<1%	30	$3.75
90656		<1%	48	$3.60
84157		<1%	71	$3.50
A9585	Injection, gadobutrol, 0.1 ml	<1%	8,494	$3.04
93325		<1%	1,021	$2.32
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	282	$2.19
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	59,945	$2.19
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	239	$1.92
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	261	$1.86
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,212	$1.78
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	216	$1.76
J0690	Injection, cefazolin sodium, 500 mg	<1%	28,938	$1.72
J1650	Injection, enoxaparin sodium, 10 mg	<1%	7,620	$1.53
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	10,364	$1.08
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	260	$0.95
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	241	$0.88
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	122	$0.86
J1630	Injection, haloperidol, up to 5 mg	<1%	9,825	$0.71
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,706	$0.69
J8540	Dexamethasone, oral, 0.25 mg	<1%	9,772	$0.62
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	84	$0.60
J2550	Injection, promethazine hcl, up to 50 mg	<1%	426	$0.46
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	203	$0.38
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	203	$0.38
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	9,684	$0.28
J2305	Injection, nitroglycerin, 5 mg	<1%	590	$0.26
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	54	$0.20
J0670	Injection, mepivacaine hydrochloride, per 10 ml	0%	3,074	$0.00
C1729	Catheter, drainage	0%	3,331	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	5,324	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	806	$0.00
C1776	Joint device (implantable)	0%	1,409	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	99	$0.00
78434		0%	339	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	4,787	$0.00
76942		0%	1,069	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	2,509	$0.00
99173		0%	270	$0.00
88302		0%	529	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	2,258	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	7,327	$0.00
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	0%	837	$0.00
77012		0%	84	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	3,131	$0.00
93356		0%	1,362	$0.00
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	0%	1,728	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	8,400	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	4,624	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	10,598	$0.00
90999	Dialysis (unlisted procedure)	0%	6,497	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	2,028	$0.00
99152		0%	5,933	$0.00
86849		0%	224	$0.00
76827		0%	221	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	4,040	$0.00
C1874	Stent, coated/covered, with delivery system	0%	513	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	1,354	$0.00
Q0508	Miscellaneous supply or accessory for use with an implanted ventricular assist device	0%	29	$0.00
82365		0%	331	$0.00
82272		0%	277	$0.00
G0271	Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes	0%	413	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	341	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	86	$0.00
90750		0%	2,215	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	284	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	1,478	$0.00
19281		0%	13	$0.00
V2630	Anterior chamber intraocular lens	0%	129	$0.00
C1758	Catheter, ureteral	0%	1,468	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	71	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	145	$0.00
95874		0%	256	$0.00
J3260	Injection, tobramycin sulfate, up to 80 mg	0%	780	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	1,027	$0.00
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	0%	42	$0.00
93319		0%	17	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	28	$0.00
S0190	Mifepristone, oral, 200 mg	0%	56	$0.00
C1757	Catheter, thrombectomy/embolectomy	0%	29	$0.00
87497		0%	16	$0.00
97598		0%	668	$0.00
97811		0%	265	$0.00
91300		0%	16,081	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	265	$0.00
82805		0%	168	$0.00
91312		0%	285	$0.00
J9171	Injection, docetaxel, 1 mg	0%	53	$0.00
76376		0%	210	$0.00
92978		0%	95	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	376	$0.00
90678		0%	87	$0.00
J9206	Injection, irinotecan, 20 mg	0%	150	$0.00
73100		0%	15	$0.00
76098		0%	48	$0.00
L3913	Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	0%	31	$0.00
77387		0%	161	$0.00
90840		0%	118	$0.00
88312		0%	31	$0.00
Q4038	Cast supplies, short leg cast, adult (11 years +), fiberglass	0%	13	$0.00
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	0%	41	$0.00
85670		0%	15	$0.00
J9000	Injection, doxorubicin hydrochloride, 10 mg	0%	31	$0.00
98966		0%	38	$0.00
A4566	Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment	0%	27	$0.00
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	0%	14	$0.00
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	0%	187	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	12	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	44	$0.00
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	0%	42	$0.00
90653		0%	172	$0.00
64643		0%	41	$0.00
95957		0%	13	$0.00
58340		0%	12	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	12	$0.00
86235		0%	21	$0.00
82108		0%	359	$0.00
59841		0%	39	$0.00
G0270	Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes	0%	43	$0.00
87400		0%	88	$0.00
73020		0%	13	$0.00
99495		0%	120	$0.00
95886		0%	2,070	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	5,952	$0.00
C1781	Mesh (implantable)	0%	440	$0.00
C1753	Catheter, intravascular ultrasound	0%	145	$0.00
C1769	Guide wire	0%	11,794	$0.00
J2704	Injection, propofol, 10 mg	0%	63,265	$0.00
95885		0%	771	$0.00
36000		0%	1,391	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	8,173	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	1,555	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	1,927	$0.00
V2632	Posterior chamber intraocular lens	0%	7,613	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	2,782	$0.00
J1815	Injection, insulin, per 5 units	0%	15,361	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	5,043	$0.00
91301		0%	4,583	$0.00
91305		0%	563	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	1,863	$0.00
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	0%	446	$0.00
88300		0%	14	$0.00
88341		0%	3,635	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	1,387	$0.00
91307		0%	403	$0.00
36416		0%	23,484	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	1,715	$0.00
80185		0%	14	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	1,558	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	3,886	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	1,010	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	1,514	$0.00
90480		0%	173	$0.00
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	0%	229	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	350	$0.00
C1783	Ocular implant, aqueous drainage assist device	0%	53	$0.00
74330		0%	324	$0.00
A9538	Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries	0%	12	$0.00
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	0%	804	$0.00
88331		0%	329	$0.00
99153	Mod sedat endo service >5yrs	0%	4,547	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	471	$0.00
A6022	Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each	0%	690	$0.00
A4648	Tissue marker, implantable, any type, each	0%	1,131	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	1,071	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	35	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	1,487	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	174	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	6,751	$0.00
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	72	$0.00
A6214	Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing	0%	568	$0.00
11045		0%	1,738	$0.00
96127		0%	395	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	261	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	283	$0.00
88311		0%	1,008	$0.00
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	0%	28	$0.00
93320		0%	14	$0.00
J2501	Injection, paricalcitol, 1 mcg	0%	9,160	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	172	$0.00
J9045	Injection, carboplatin, 50 mg	0%	1,444	$0.00
91303		0%	890	$0.00
90839		0%	481	$0.00
J0706	Injection, caffeine citrate, 5 mg	0%	527	$0.00
91306		0%	890	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	2,280	$0.00
0352U		0%	992	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	290	$0.00
A4217	Sterile water/saline, 500 ml	0%	753	$0.00
94760		0%	15	$0.00
99496		0%	553	$0.00
L8699	Prosthetic implant, not otherwise specified	0%	112	$0.00
J0280	Injection, aminophyllin, up to 250 mg	0%	123	$0.00
77001		0%	153	$0.00
72190		0%	71	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	40	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	62	$0.00
76377		0%	53	$0.00
97804		0%	15	$0.00
89060		0%	21	$0.00
36226		0%	31	$0.00
99386		0%	15	$0.00
J0456	Injection, azithromycin, 500 mg	0%	59	$0.00
C1768	Graft, vascular	0%	27	$0.00
86160		0%	32	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	21	$0.00
J7999	Compounded drug, not otherwise classified	0%	14	$0.00
J0697	Injection, sterile cefuroxime sodium, per 750 mg	0%	329	$0.00
84300		0%	12	$0.00
Q2039	Influenza virus vaccine, not otherwise specified	0%	28	$0.00
86777		0%	16	$0.00
99385		0%	17	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	28	$0.00
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	0%	26	$0.00
L3906	Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARCHOZZI, THOMAS (V.P. FINANCE)

Same official

Other billing entities under MARCHOZZI, THOMAS

Full network →

Provider	Location	Paid
Lehigh Valley Hospital - Coordinated Health Allentown	Allentown, PA	$2.40M
LVHN Coordinated Professional Practice	Allentown, PA	$729K
LVHN Scranton Orthopedic Specialists	Dickson City, PA	$40K
Pocono Kids Dental	East Stroudsburg, PA	$32K
LVHN Ambulatory Surgery Center of Lopatcong, INC.	Phillipsburg, NJ	$27K
Lehigh Valley Hospital - Coordinated Health Bethlehem	Bethlehem, PA	$23K
LVHN Coordinated Professional Practice of NJ, PC	Phillipsburg, NJ	$23K
Lehigh Valley Hospital Muhlenberg	Bethlehem, PA	$18K
Lehigh Valley Hospital Muhlenberg	Bethlehem, PA	$4K
Schuylkill Medical Center - South Jackson Street Spu	Pottsville, PA	$913.99

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.